Global Healthcare CRO Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Healthcare CRO Market Research Report 2024
Contract research organizations (CROs) have transformed the way research are conducted by several pharmaceutical, biotechnology, and medical devices companies in ways more than one. These organizations offer a variety of services such as biopharmaceutical development, clinical trials conduct and other endeavors, drug discovery activities, product commercialization, assay development, and pharmacovigilance. The intensifying demand for new therapies and devices has mounted pressures on research and development (R&D) budgets of these organizations.
According to Mr Accuracy reports’s new survey, global Healthcare CRO market is projected to reach US$ 62340 million in 2034, increasing from US$ 42030 million in 2024, with the CAGR of 5.7% during the period of 2023 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Healthcare CRO market research.
Key companies engaged in the Healthcare CRO industry include Quintiles Transnational Holdings, Laboratory Corporation Of America Holdings, Pharmaceutical Product Development, PAREXEL International, ICON plc, PRA Health Sciences, InVentiv Health, Charles River Laboratories and INC Research Holdings, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2024.
When refers to consumption region, % value of Healthcare CRO were sold to North America, Europe and Asia Pacific in 2024. Moreover, China, plays a key role in the whole Healthcare CRO market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2024) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Healthcare CRO market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Quintiles Transnational Holdings
Laboratory Corporation Of America Holdings
Pharmaceutical Product Development
PAREXEL International
ICON plc
PRA Health Sciences
InVentiv Health
Charles River Laboratories
INC Research Holdings
Wuxi PharmaTech
Segment by Type
Early Phase Development
Clinical Research
Laboratory
Consulting Services
Biopharmaceutical Companies
Academic and Research Institutes
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Healthcare CRO report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to Mr Accuracy reports’s new survey, global Healthcare CRO market is projected to reach US$ 62340 million in 2034, increasing from US$ 42030 million in 2024, with the CAGR of 5.7% during the period of 2023 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Healthcare CRO market research.
Key companies engaged in the Healthcare CRO industry include Quintiles Transnational Holdings, Laboratory Corporation Of America Holdings, Pharmaceutical Product Development, PAREXEL International, ICON plc, PRA Health Sciences, InVentiv Health, Charles River Laboratories and INC Research Holdings, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2024.
When refers to consumption region, % value of Healthcare CRO were sold to North America, Europe and Asia Pacific in 2024. Moreover, China, plays a key role in the whole Healthcare CRO market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2024) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Healthcare CRO market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Quintiles Transnational Holdings
Laboratory Corporation Of America Holdings
Pharmaceutical Product Development
PAREXEL International
ICON plc
PRA Health Sciences
InVentiv Health
Charles River Laboratories
INC Research Holdings
Wuxi PharmaTech
Segment by Type
Early Phase Development
Clinical Research
Laboratory
Consulting Services
Segment by Application
Biopharmaceutical Companies
Academic and Research Institutes
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Healthcare CRO report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source